Michigan Medicine Executive Leadership

David C. Miller, M.D., M.P.H.
President, University of Michigan Health System
Executive Vice Dean for Clinical Affairs
Professor of Urology
University of Michigan Medical School

David Miller

Dr. David Miller has served as President, University of Michigan Health System and Executive Vice Dean for Clinical Affairs, University of Michigan Medical School since January 1, 2021. University of Michigan Health System is composed of C.S. Mott Children's Hospital, the Von Voigtlander Women's Hospital, University Hospital, Frankel Cardiovascular Center, and the University of Michigan Medical Group, including 2,000 physicians, and 140 clinics at 40 sites throughout Southeastern Michigan. In this role, Dr. Miller oversees all activities of the health system that serves patients from throughout Michigan and around the world.

Dr. Miller served as Chief Clinical Officer for University Hospital and the Frankel Cardiovascular Center from 2018-2020. Working in partnership with the Chief Operating Officer and Chief Nursing Officer, Dr. Miller provided clinical operational leadership to ensure quality and safety in clinical programs and patient care, improve patient experience, enhance staff engagement, and optimize capacity management within the two adult hospitals.

Dr. Miller is a Professor in the Department of Urology and maintains a clinical practice that focuses on the diagnosis and management of patients with prostate cancer.

In addition to his clinical practice, Dr. Miller served as Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC) 2011 through 2020. Funded by Blue Cross Blue Shield of Michigan (BCBSM), MUSIC is a consortium of more than 40 urology practices aiming to improve the quality and cost-efficiency of urological care in the state of Michigan.

Dr. Miller also has a broad background in health services research, including substantial experience using claims data and formal training in the advanced statistical methods used in observational data analyses. With prior funding from the Agency for Healthcare Research & Quality and the National Cancer Institute, Dr. Miller's empirical research agenda focused on comparative effectiveness research, physician-led collaborative quality improvement, and understanding the relationship between physician organizations, integrated delivery systems, and the quality and cost of specialty care.